Zions Bancorporation N.A. Buys 2,816 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Zions Bancorporation N.A. lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 15.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,608 shares of the company’s stock after purchasing an additional 2,816 shares during the quarter. Zions Bancorporation N.A.’s holdings in HealthEquity were worth $1,687,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. International Assets Investment Management LLC bought a new position in HealthEquity in the 2nd quarter valued at about $35,000. Paladin Wealth LLC bought a new position in HealthEquity in the 3rd quarter valued at about $39,000. GAMMA Investing LLC lifted its position in HealthEquity by 114.8% in the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after acquiring an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in HealthEquity in the 2nd quarter valued at about $73,000. Finally, 1620 Investment Advisors Inc. bought a new position in HealthEquity in the 3rd quarter valued at about $112,000. Institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently weighed in on HQY. Barrington Research reaffirmed an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research report on Friday, September 20th. BTIG Research increased their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday. Bank of America increased their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $107.17.

HealthEquity Stock Up 0.9 %

Shares of NASDAQ:HQY opened at $95.70 on Friday. The firm has a fifty day moving average price of $84.56 and a two-hundred day moving average price of $80.94. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. HealthEquity, Inc. has a one year low of $62.10 and a one year high of $101.17. The company has a market cap of $8.36 billion, a price-to-earnings ratio of 79.75, a PEG ratio of 1.48 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. Analysts anticipate that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

Insider Transactions at HealthEquity

In related news, Director Frank Corvino sold 1,039 shares of HealthEquity stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now owns 3,784 shares in the company, valued at $363,642.40. This trade represents a 21.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,536 shares of company stock valued at $884,517. Insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.